Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03470428 · ClinicalTrials.gov registry record
Clinical Characteristics and Associations of the "Good Fontan" Patient
A clinical trial of Congenital Heart Disease and Single-ventricle, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 146
- Enrollment target
- 1
- Study location
NCT03470428: Completed study of Congenital Heart Disease and Single-ventricle, sponsored by Boston Children's Hospital.
NCT03470428 is a study of Congenital Heart Disease and Single-ventricle that has completed, run by Boston Children's Hospital. The registered enrollment target is 146 participants, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03470428, a study of Congenital Heart Disease and Single-ventricle, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine what are some of the clinical characteristics and associations of Fontan patients who are doing well, as well as how accurate cardiology providers are at predicting the likelihood of future adverse event in their Fontan patients.
Primary Outcome
The ability of the cardiologist's response to the "surprise" question to predict adverse cardiac events within 1 year
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2023-04-18 |
What the finished NCT03470428 record still lists
NCT03470428 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03470428 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03470428 about?
NCT03470428 is a clinical study titled "Clinical Characteristics and Associations of the "Good Fontan" Patient". This study aims to determine what are some of the clinical characteristics and associations of Fontan patients who are doing well, as well as how accurate cardiology providers are at predicting the likelihood of future adverse event in their Fontan patients.
What is the current status of trial NCT03470428?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2018-03-05. Estimated completion is 2023-04-18.
What conditions does trial NCT03470428 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Single-ventricle.
Who is sponsoring clinical trial NCT03470428?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03470428 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03470428's enrollment target sits among peer trials
146 26th of 63 higher than 38 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI